Is Carboxymethylcellulose + Erythromycin + Glycerol + Hyaluronate registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Carboxymethylcellulose + Erythromycin + Glycerol + Hyaluronate.

Active substances

Carboxymethylcellulose + Erythromycin + Glycerol + Hyaluronate

SFDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ULTRA-FUSION Ophthalmic Solution	9,5,1,5 mg/ml,mg/ml,mg/ml,mg/ml	Eye drops · Ophthalmic use	1 Bottle	SAR 30.50	Generic · OTC	Jamjoom Pharmaceuticals Factory Company	Withdrawn by MAH · Not Marketed

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.